YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Sanofi Buys More Regeneron Biotech Stocks


February 12, 2013 | Sanofi is buying more shares of Regeneron Pharmaceuticals, its current partner on cholesterol and rheumatoid arthritis. Sanofi currently controls 16.7% of the company but has the right to control up to 30%. Both company's stocks rose on the announcement. Reuters
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.